-
公开(公告)号:US5763458A
公开(公告)日:1998-06-09
申请号:US456168
申请日:1995-05-31
申请人: Robin Douglas Clark , Richard Malcolm Eglen , John Otis Gardner , Alam Jahangir , Aaron Bayne Miller
发明人: Robin Douglas Clark , Richard Malcolm Eglen , John Otis Gardner , Alam Jahangir , Aaron Bayne Miller
IPC分类号: C07D295/10 , A61K31/136 , A61K31/335 , A61K31/357 , A61K31/36 , A61K31/40 , A61K31/4409 , A61K31/4418 , A61K31/4425 , A61K31/443 , A61K31/445 , A61K31/4465 , A61K31/451 , A61P1/00 , A61P9/00 , A61P13/00 , A61P13/02 , A61P15/00 , A61P25/00 , A61P43/00 , C07C225/22 , C07C239/16 , C07C259/10 , C07D207/09 , C07D211/14 , C07D211/20 , C07D211/32 , C07D211/34 , C07D211/46 , C07D211/58 , C07D211/62 , C07D213/46 , C07D295/03 , C07D295/108 , C07D317/58 , C07D317/66 , C07D319/18 , C07D405/06 , C07D487/08
CPC分类号: C07D295/108 , C07C225/22 , C07C259/10 , C07D211/32 , C07D211/34 , C07D211/46 , C07D211/58 , C07D211/62 , C07D317/66 , C07D319/18
摘要: The present invention relates to novel 5-HT.sub.4 receptor ligands which are 1-(5-halo-4-aminophenyl) (C.sub.2-6)alkan-1-one derivatives in which the 5-halo-4-aminophenyl group is substituted at its 2-position with (C.sub.1-4)alkyloxy or phenyl(C.sub.1-4)alkyloxy and optionally substituted at its 3-position with (C.sub.1-4)alkyloxy or substituted at its 2- and 3-positions together with methylenedioxy or ethylenedioxy and the highest numbered carbon of the (C.sub.2-6)alkan-1-one is substituted with di(C.sub.1-4)alkylamino, morpholin-1-yl or pyrrolidin-1-yl or optionally substituted piperidin-1-yl, piperidin-4-yl, azacyclohept-1-yl, azabicyclo�2.2.1!hept-3-yl, azabicylo�2.2.2!oct-3-yl or azabicylo�3.2.2!non-3-yl; and the pharmaceutically acceptable salts, individual isomers and mixtures of isomers and methods of using and making such derivatives.
摘要翻译: 本发明涉及5-(5-卤代-4-氨基苯基)(C 2-6)烷-1-酮衍生物的新型5-HT 4受体配体,其中5-卤代-4-氨基苯基在其 (C 1-4)烷氧基或苯基(C 1-4)烷氧基,并且其3-位上任选被(C 1-4)烷氧基取代或在其2-和3-位与亚甲二氧基或亚乙二氧基取代, (C2-6)烷基-1-酮的最高编号的碳被二(C 1-4)烷基氨基,吗啉-1-基或吡咯烷-1-基或任选取代的哌啶-1-基,哌啶-4-基, 氮杂环庚烯-1-基,氮杂双环[2.2.1]庚-3-基,氮杂双环[2.2.2]辛-3-基或氮杂双环[3.2.2]壬-3-基; 和其药学上可接受的盐,各异构体和异构体的混合物以及使用和制备这些衍生物的方法。